Skip to content
DirectHeadline

The Zimbabwean Government Turns Down ‘Lopsided’ American Healthcare Assistance Deal Over Data Concerns

Medical funding illustration
The offered American financial assistance was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has declined a substantial American health deal valued at 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for confidential data.

This rejection was revealed following a government memo dated December was leaked, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".

An official representative later explained that the United States was seeking health data for research and profit but refused to share the resulting advantages from future medical innovations.

"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has called for more negotiations to find a deal acceptable to all parties so the nation's critical HIV programme can continue.

Wider Background

This rejection follows a similar situation in Kenya, where a high court blocked a related health funding agreement after legal challenges were filed about the safety of Kenyans' medical information.

Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.

The agency had managed aid for the American government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government deals to enhance transparency and responsibility.

According to reports, 16 African countries have so far agreed to similar health pacts, constituting more than $18.3bn in new funding.

Specifics of the Rejected Agreement

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".

"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding assurance of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," his statement read.

"In essence, our nation would supply the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our population if a future pandemic arise."

National Interest and International Frameworks

He also noted that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks already set up through the global health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.

"This system is intended to guarantee that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."

The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage continued dialogue with our American counterparts on how subsequent co-operation could be structured in a manner that honours the sovereignty and dignity of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but urged that talks need to persist given that much of the country's Aids initiatives were funded by external financing.

"Where technical issues exist, such as those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," it said.

The situation highlights the continuing debate between accepting much-needed foreign assistance and protecting local interests in an increasingly data-driven world.

About the author

Amanda Vang

Award-winning journalist with over a decade of experience covering international affairs and investigative reporting.

DirectHeadline

Type to search articles.